Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

Ahmed Omar Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean Nicolas Vauthey, Sunyoung S. Lee, Betul Gok Yavuz, Yehia I. Mohamed, Aliya Qayyum, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S. Yadav, Courtney Nicholas, Jing Jing Sun, Kanwal Pratap Singh Raghav, Asif Rashid, Kristen Carter, Yun Shin Chun, Ching Wei David TzengDivya Sakamuri, Li Xu, Ryan Sun, Vittorio Cristini, Laura Beretta, James C. Yao, Robert A. Wolff, James Patrick Allison, Padmanee Sharma

Research output: Contribution to journal › Article › peer-review

95 Scopus citations

Fingerprint

Dive into the research topics of 'Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences